Related Experiment Video
Updated: May 3, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
Christos Koros1, Maria-Eleftheria Evangelopoulos1, Costas Kilidireas1
11st Department of Neurology, Athens National University, "Aeginition" Hospital, 74 Vas. Sophia's Avenue, 11528 Athens, Greece.
Abstract:
Introduction. Central nervous system involvement, either clinical or subclinical, has been reported mainly in X-linked Charcot-Marie-Tooth (CMT-X) patients. Case Presentation. We present the case of a 31-year-old man with a genetically confirmed history of CMT1A who developed CNS involvement mimicking multiple sclerosis (MS). Clinical, imaging, and laboratory findings suggested an autoimmune CNS demyelination. Discussion. Although the simultaneous existence of CMT1A and MS could be coincidental we postulate that overexpression of PMP22, the target protein in CMT1A, might influence the immunological self-tolerance to CNS proteins via molecular mimicry, leading to a CNS autoimmune demyelinating disorder.
Related Concept Videos
Multiple Sclerosis l: Introduction
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Myasthenia Gravis ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Diabetic Neuropathy

